•
PU
PULM
Pulmatrix, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
9.61M
Volume
29.53K
52W High
$10.40
52W Low
$2.15
Open
$0.00
Prev Close
$2.66
Day Range
0.00 - 0.00
About Pulmatrix, Inc. Common Stock
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Latest News
Pulmatrix, Inc. (PULM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks Investment Research•Sep 11
HOOKIPA Pharma Inc. (HOOK) Reports Q2 Loss, Lags Revenue Estimates
Zacks Investment Research•Aug 10
UniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
Zacks Investment Research•Aug 1
Why Splunk Is Trading Lower By Around 10%; Here Are 28 Stocks Moving Premarket
Benzinga•Aug 25
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 9
Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 5
Pulmatrix, Inc. (PULM) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research•Nov 10
Pulmatrix, Inc. (PULM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Zacks Investment Research•Nov 4